Akèy › Lekemi selil B › Washington › Spokane
Etid klinik pou Lekemi selil B nan Spokane, WA
3 etid pou Lekemi selil B ap chèche patisipan nan sit nan ak bò kote Spokane (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
Ap rekriteFaz 2
- Medical Oncology Associates (Summit Cancer Centers) ( Site 2710), Spokane
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Ap rekriteFaz 3
- Medical Oncology Associates, PS, Spokane
ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
Ap rekriteFaz 3
- Medical Oncology Associates - Spokane, Spokane
Etid Lekemi selil B nan lòt vil
- Houston, TX7 etid
- Washington, DC5 etid
- Dallas, TX5 etid
- Columbus, OH4 etid
- Portland, OR4 etid
- Philadelphia, PA3 etid
- New York City, NY3 etid
- Boston, MA3 etid
- Clifton, NJ3 etid
- San Diego, CA3 etid
- Charlotte, NC3 etid
- Louisville, KY3 etid
Lòt etid nan Spokane
- Kansè Poumon ki pa ti selil12 etid
- Kansè nan tete8 etid
- Kansè ovè8 etid
- Kansè kolorektal8 etid
- Maladi Parkinson7 etid
- Kansè pwostat6 etid
- Lukemi lenfositè kwonik6 etid
- Karsinòm selil skuamèz tèt ak kou6 etid
- Kansè (tout kalite)6 etid
- Kansè tete negatif triple5 etid
- Melanom5 etid
- Degeneresans makile5 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 3, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.